000			01547 a2200421 4500
005			20250515154115.0
264		0	_c20090202
008			200902s 0 0 eng d
022			_a1460-2105
024	7		_a10.1093/jnci/djn442 _2doi
040			_aNLM _beng _cNLM
100	1		_aRebbeck, Timothy R
245	0	0	_aMeta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. _h[electronic resource]
260			_bJournal of the National Cancer Institute _cJan 2009
300			_a80-7 p. _bdigital
500			_aPublication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aBreast Neoplasms _xgenetics
650	0	4	_aCase-Control Studies
650	0	4	_aCohort Studies
650	0	4	_aFallopian Tubes _xsurgery
650	0	4	_aFemale
650	0	4	_aGenes, BRCA1
650	0	4	_aGenes, BRCA2
650	0	4	_aGerm-Line Mutation
650	0	4	_aHeterozygote
650	0	4	_aHumans
650	0	4	_aOdds Ratio
650	0	4	_aOvarian Neoplasms _xgenetics
650	0	4	_aOvariectomy
650	0	4	_aPrimary Prevention _xmethods
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aRisk Reduction Behavior
700	1		_aKauff, Noah D
700	1		_aDomchek, Susan M
773	0		_tJournal of the National Cancer Institute _gvol. 101 _gno. 2 _gp. 80-7
856	4	0	_uhttps://doi.org/10.1093/jnci/djn442 _zAvailable from publisher's website
999			_c18589758 _d18589758